Mirae Asset Global ETFs Holdings
ELDN icon

Mirae Asset Global ETFs Holdings’s Eledon Pharmaceuticals ELDN Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$140K Buy
35,473
+419
+1% +$1.52K ﹤0.01% 2655
2026
Q1 		$108K Buy
35,054
+8,299
+31% +$19.5K ﹤0.01% 2630
2025
Q4 		$40.4K Sell
26,755
-828
-3% -$1.97K ﹤0.01% 2977
2025
Q3 		$71.4K Sell
27,583
-4,469
-14% -$13.1K ﹤0.01% 2818
2025
Q2 		$86.9K Buy
+32,052
New +$96.2K ﹤0.01% 2678

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $747M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Catalio Capital Management New York $532M AUM 166.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ZP
Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ELDN Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Eledon Pharmaceuticals (ELDN) stake by 1.2% in Q2 2026, buying an estimated $1.52K and bringing the position to 35,473 shares worth $140K. The position accounts for ﹤0.01% of the portfolio, ranked #2655.

Mirae Asset Global ETFs Holdings first reported a position in ELDN in Q2 2025 and has held it in 5 quarters since. 160 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 35,473 shares of Eledon Pharmaceuticals worth $140K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 419 Eledon Pharmaceuticals shares in Q2 2026, an estimated $1.52K.
  • Eledon Pharmaceuticals made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2655 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Eledon Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 160 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.